Advanced rai stage in patients with chronic lymphocytic leukaemia correlates with simultaneous hypermethylation of plural tumour suppressor genes

Folia Biologica

Volumn 56, Issue 4, 2010, Pages 158-164

  Forsterová, Kristina ^a   Votavova H ^a   Schwarz, J ^b   Karban, J ^a   Stuka C ^a   Trneny M ^a,b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

Author keywords

Aberrant hypermethylation; Chronic lymphocytic leukaemia; Methylation specific polymerase chain reaction; Rai stage; Tumour suppressor genes

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DLC1 GENE; FEMALE; GENE SILENCING; HUMAN; LAMIN A GENE; LAMIN C GENE; MALE; METHYLATION; P15 GENE; P16 GENE; POLYMERASE CHAIN REACTION; PROMOTER REGION; SHP1 GENE; TUMOR SUPPRESSOR GENE;

EID: 77956659846     PISSN: 00155500     EISSN: 25337602     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. Agrelo, R., Setien, F., Espada, J., Artiga, M. J., Rodriguez, M., Perez-Rosado, A., Sanchez-Aguilera, A., Fraga, M. F., Piris, M. A., Esteller, M. (2005) Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma. J. Clin. Oncol. 23, 3940-3947.
2. Amara, K., Trimeche, M., Ziadi, S., Laatiri, A., Hachana, M., Sriha, B., Mokni, M., Korbi, S. (2007) Presence of simian virus 40 DNA sequences in diffuse large B-cell lymphomas in Tunisia correlates with aberrant promoter hypermethylation of multiple tumor suppressor genes. Int. J. Cancer 121, 2693-2702.
3. Amara, K., Trimeche, M., Ziadi, S., Laatiri, A., Hachana, M. Korbi, S. (2008) Prognostic significance of aberrant promoter hypermethylation of CpG islands in patients with diffuse large B-cell lymphomas. Ann. Oncol. 19, 1774-1786.
4. Baylin, S. B., Herman, J. G. (2000) DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 16, 168-174.
5. Binet, J. L., Auquier, A., Dighiero, G., Chastang, C., Piguet, H., Goasguen, J., Vaugier, G., Potron, G., Colona, P., Oberling, F., Thomas, M., Tchernia, G., Jacquillat, C., Boivin, P., Lesty, C., Duault, M. T., Monconduit, M., Belabbes, S., Gremy, F. (1981) A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48, 198-206.
6. Broers, J. L., Machiels, B. M., Kuijpers, H. J., Smedts, F., van den Kieboom, R., Raymond, Y., Ramaekers, F. C. (1997) A- and B-type lamins are differentially expressed in normal human tissues. Histochem. Cell Biol. 107, 505-517.
7. Broers, J. L., Hutchison, C. J., Ramaekers, F. C. (2004) Laminopathies. J. Pathol. 204, 478-488.
8. Cairns, P., Polascik, T. J., Eby, Y., Tokino, K., Califano, J., Merlo, A., Mao, L., Herath, J., Jenkins, R., Westra, W., Rutter, J. L., Buckler, A., Gabrielson, E., Tockman, M., Cho, K. R., Hedrick, L., Bova, G. S., Issacs, W., Schwab, D., Sidransky, D. (1995) Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat. Genet. 11, 210-212.
9. Calin, G. A., Liu, C. G., Sevignani, C., Ferracin, M., Felli, N., Dumitru, C. D., Shimizu, M., Cimmino, A., Zupo, S., Dono, M., Dell'Aquila, M. L, Alder, H., Rassenti, L., Kipps, T. J., Bullrich, F., Negrini, M., Croce, C. M. (2004) MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc. Natl. Acad. Sci. USA 101, 11755-11760.
10. Chen, C. Z., Lodish, H. F. (2005) MicroRNAs as regulators of mammalian hematopoiesis. Semin. Immunol. 17, 155-165.
11. Cheson, B. D., Bennett, J. M., Grever, M., Kay, N., Keating, M. J., O'Brien, S., Rai, K. R. (1996) National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 87, 4990-4997.
12. Chim, C. S., Liang, R., Kwong, Y. L. (2002) Hypermethylation of gene promoters in hematological neoplasia. Hematol. Oncol. 20, 167-176.
13. Chim, C. S., Wong, K. Y., Loong, F., Srivastava, G. (2004) SOCS1 and SHP1 hypermethylation in mantle cell lymphoma and follicular lymphoma: implications for epigenetic activation of the Jak/STAT pathway. Leukemia 18, 356-358.
14. Chim, C. S., Fung, T. K., Wong, K. F., Lau, J. S., Law, M., Liang, R. (2006) Methylation of INK4 and CIP/KIP families of cyclin-dependent kinase inhibitor in chronic lymphocytic leukaemia in Chinese patients. J. Clin. Pathol. 59, 921-926.
15. Chim, C. S., Liang, R., Leung, M. H., Kwong, Y. L. (2007) Aberrant gene methylation implicated in the progression of monoclonal gammopathy of undetermined significance to multiple myeloma. J. Clin. Pathol. 60, 104-106.
16. Crespo, M., Bosch, F., Villamor, N., Bellosillo, B., Colomer, D., Rozman, M., Marcé, S., López-Guillermo, A., Campo, E., Montserrat, E. (2003) ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N. Engl. J. Med. 348, 1764-1775. (Pubitemid 36514707)
17. Cyster, J. G., Goodnow, C. C. (1995) Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. Immunity 2, 13-24.
18. Damle, R. N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S. L., Buchbinder, A., Budman, D., Dittmar, K., Kolitz, J., Lichtman, S. M., Schulman, P., Vinciguerra, V. P., Rai, K. R., Ferrarinni, M., Chiorazzi, N. (1999) IgV gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94, 1840-1847.
19. Dohner, H., Stilgenbauer, S., James, M. R., Benner, A., Weilguni, T., Bentz, M. Fischer, K., Hunstein, W., Lichter, P. (1997) 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood, 89, 2516-2522.
20. Dohner, H., Stilgenbauer, S., Benner, A., Leupolt, E., Krober, A., Bullinger, L., Döhner, K., Bentz, M., Lichter, P. (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. N. Engl. J. Med. 343, 1910-1916. (Pubitemid 32064784)
21. Foster, S. A., Wong, D. J., Barrett, M. T., Galloway, D. A. (1998) Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol. Cell. Biol. 18, 1793-1801.
22. Guan, M., Zhou, X., Soulitzis, N., Spandidos, D. A., Popescu, N. C. (2006) Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications. Clin. Cancer Res. 12, 1412-1419.
23. Guarini, A., Gaidano, G., Mauro, F. R., Capello, D., Mancini, F., De Propris, M. S., Mancini, M., Orsini, E., Gentile, M., Breccia, M., Cuneo, A., Castoldi, G., Foa, R.. (2003) Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features. Blood 102, 1035-1041.
24. Hamblin, T. J., Davis, Z., Gardiner, A., Oscier, D. G., Stevenson, F. K. (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94, 1848-1854.
25. Hamblin, T. J., Orchard, J. A., Ibbotson, R. E., Davis, Z., Thomas, P. W., Stevenson, F. K., Oscier, D. G. (2002) CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood, 99 1023-1029.
26. Herman, J. G., Merlo, A., Mao, L., Lapidus, R. G., Issa, J. P., Davidson, N. E., Sidransky, D., Baylin, S. B. (1995) Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 55, 4525-4530.
27. Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D., Baylin, S. B. (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 93, 9821-9826.
28. Herman, J. G., Civin, C. I., Issa, J. P., Collector, M. I., Sharkis, S. J., Baylin, S. B. (1997) Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies. Cancer Res. 57, 837-841.
29. Herman, J. G., Baylin, S. B. (2003) Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 349, 2042-2054.
30. Hirama, T., Koeffler, H. P. (1995) Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 86, 841-854.
31. Hutchison, C. J., Worman, H. J. (2004) A-type lamins: guardians of the soma? Nat. Cell Biol. 6, 1062-1067.
32. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S. 3rd, Johnson, B. E., Skolnick, M. H. (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264, 436-440.
33. Kim, T. Y., Jong, H. S., Song, S. H., Dimtchev, A., Jeong, S. J., Lee, J. W., Kim, T. Y., Kim, N. K., Jung, M., Bang, Y. J. (2003) Transcriptional silencing of the DLC1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells. Oncogene 22, 3943-3951.
34. Kim, T. Y., Lee, J. W., Kim, H. P., Jong, H. S., Kim, T. Y., Jung, M., Bang, Y. J. (2007) DLC1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma. Biochem. Biophys. Res. Commun. 355, 72-77.
35. Koh, J., Enders, G. H., Dynlacht, B. D. and Harlow, E. (1995) Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature 375, 506-510.
36. Koyama, M., Oka, T., Ouchida, M., Nakatani, Y., Nishiuchi, R., Yoshino, T., Hayashi, K., Akagi, T., Seino, Y. (2003) Activated proliferation of B-cell lymphomas/leukemias with the SHP1 gene silencing by aberrant CpG methylation. Lab. Invest. 83, 1849-1858.
37. Krober, A., Seiler, T., Benner, A., Bullinger, L., Bruckle, E., Lichter, P., Döhner, H., Stilgenbauer, S. (2002) V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 100, 1410-1416.
38. Lin, F., Worman, H. J. (1997) Expression of nuclear lamins in human tissues and cancer cell lines and transcription from the promoters of the lamin A/C and Bl genes. Exp. Cell Res. 236, 378-384.
39. Martel, V., Guerci, A., Humbert, J. C., Gregoire, M. J., Chery, M., Lederlin, P., Jonveaux, P. (1997) De novo methylation of tumour suppressor genes CDKN2A and CDKN2B is a rare finding in B-cell chronic lymphocytic leukaemia. Br. J. Haematol. 99, 320-324.
40. Miller, S. A., Dykes, D. D., Polesky, H. F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16, 1215.
41. Ng, I. O., Liang, Z. D., Cao, L., Lee, T. K. (2000) DLC1 is deleted in primary hepatocellular carcinoma and exerts inhibitory effects on the proliferation of hepatoma cell lines with deleted DLC1. Cancer Res. 60, 6581-6584.
42. Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., Carson, D. A. (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368, 753-756.
43. Oka, T., Ouchida, M., Koyama, M., Ogama, Y., Takada, S., Nakatani, Y., Tanaka, T., Yoshino, T., Hayashi, K., Ohara, N., Kondo, E., Takahashi, K., Tsuchiyama, J., Tanimoto, M., Shimizu, K., Akagi, T. (2002) Gene silencing of the tyrosine phosphatase SHPl gene by aberrant methylation in leukemias/lymphomas. Cancer Res. 62, 6390-6394.
44. Oscier, D. G., Gardiner, A. C., Mould, S. J., Glide, S., Davis, Z. A., Ibbotson, R. E., Corcoran, M. M., Chapman, R. M., Thomas, P., Copplestone, J. A., Orchard, J. A., Hamblin, T. J.H., (2002) Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood 100, 1177-1184.
45. Pani, G., Kozlowski, M., Cambier, J. C., Mills, G. B., Siminovitch, K. A. (1995) Identification of the tyrosine phosphatase PTP1C as a B cell antigen receptor-associated protein involved in the regulation of B cell signaling. J. Exp. Med. 181, 2077-2084.
46. Papageorgiou, S. G., Lambropoulos, S., Pappa, V., Economopoulou, C., Kontsioti, F., Papageorgiou, E., Tsirigotis P, Dervenoulas, J., Economopoulos, T. (2007) Hypermethylation of the p15INK4B gene promoter in B-chronic lymphocytic leukemia. Am. J. Hematol. 82, 824-825.
47. Pike, B. L., Greiner, T. C., Wang, X., Weisenburger, D. D., Hsu, Y. H., Renaud, G., Wolfsberg, T. G., Kim, M., Weisenberger, D. J., Siegmund, K. D., Ye, W., Groshen, S., Mehrian-Shai, R., Delabie, J., Chan, W. C., Laird, P. W., Hacia, J. G. (2008) DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status. Leukemia 22, 1035-1043.
48. Plaumann, M., Seitz, S., Frege, R., Estevez-Schwarz, L., Scherneck, S. (2003) Analysis of DLC1 expression in human breast cancer. J. Cancer Res. Clin. Oncol. 129, 349-354.
49. Rai, K. R., Sawitsky, A., Cronkite, E. P., Chanana, A. D., Levy, R. N., Pasternack, B. S. (1975) Clinical staging of chronic lymphocytic leukemia. Blood 46, 219-234.
50. Rassenti, L. Z., Huynh, L., Toy, T. L., Chen, L., Keating, M. J., Gribben, J. G., Neuberg, D. S., Flinn, I. W., Rai, K. R., Byrd, J. C., Kay, N. E., Greaves, A., Weiss, A., Kipps, T. J. (2004) ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N. Engl. J. Med. 351, 893-901.
51. Reddy, J., Shivapurkar, N., Takahashi, T., Parikh, G., Stastny, V., Echebiri, C., Crumrine, K., Zöchbauer-Müller, S., Drach, J., Zheng, Y., Feng, Z., Kroft, S. H., McKenna, R. W., Gazdar, A. F. (2005) Differential methylation of genes that regulate cytokine signaling in lymphoid and hematopoietic tumors. Oncogene 24, 732-736.
52. Rober, R. A., Weber, K., Osborn, M. (1989) Differential timing of nuclear lamin A/C expression in the various organs of the mouse embryo and the young animal: a developmental study. Development 105, 365-378.
53. Robertson, K. D., Wolffe, A. P. (2000) DNA methylation in health and disease. Nat. Rev. Genet. 1, 11-19.
54. Rosenwald, A., Alizadeh, A. A., Widhopf, G., Simon, R., Davis, R. E., Yu, X., Yang, L., Pickeral, O. K., Rassenti, L. Z., Powell, J., Botstein, D., Byrd, J. C., Grever, M. R., Cheson, B. D., Chiorazzi, N., Wilson, W. H., Kipps, T. J., Brown, P. O., Staudt, L. M. (2001) Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J. Exp. Med. 194, 1639-1647.
55. Rush, L. J., Raval, A., Funchain, P., Johnson, A. J., Smith, L., Lucas, D. M., Bembea, M., Liu, T. H., Heerema, N. A., Rassenti, L., Liyanarachchi, S., Davuluri, R., Byrd, J. C., Plass, C. (2004) Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets. Cancer Res. 64, 2424-2433.
56. Seeliger, B., Wilop, S., Osieka, R., Galm, O., Jost, E. (2009) CpG island methylation patterns in chronic lymphocytic leukemia. Leuk. Lymphoma 50, 419-426.
57. Seng, T. J., Low, J. S., Li, H., Cui, Y., Goh, H. K., Wong, M. L., Srivastava, G., Sidransky, D., Califano, J., Steenbergen, R. D., Rha, S. Y., Tan, J., Hsieh, W. S., Ambinder, R. F., Lin, X., Chan, A. T., Tao, Q. (2007) The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation. Oncogene 26, 934-944.
58. Shi, H., Guo, J., Duff, D. J., Rahmatpanah, F., Chitima-Matsiga, R., Al-Kuhlani, M., Taylor, K. H., Sjahputera, O., Andreski, M., Wooldridge, J. E., Caldwell, C. W. (2007) Discovery of novel epigenetic markers in non-Hodgkin's lymphoma. Carcinogenesis 28, 60-70.
59. Singal, R., Ginder, G. D. (1999) DNA methylation. Blood 93, 4059-4070.
60. Song, Y. F., Xu, R., Zhang, X. H., Chen, B. B., Chen, Q., Chen, Y. M., Xie, Y. (2006) High-frequency promoter hypermethylation of the deleted in liver cancer-1 gene in multiple myeloma. J. Clin. Pathol. 59, 947-951.
61. Stadelmann, B., Khandjian, E., Hirt, A., Luthy, A., Weil, R., Wagner, H. P. (1990) Repression of nuclear lamin A and C gene expression in human acute lymphoblastic leukemia and non-Hodgkin's lymphoma cells. Leuk. Res. 14, 815-821.
62. Stilgenbauer, S., Bullinger, L., Lichter, P., Dohner, H. (2002) Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course. Leukemia 16, 993-1007.
63. Thunberg, U., Johnson, A., Roos, G., Thorn, I., Tobin, G., Sallstrom, J., Sundström, C., Rosenquist, R. (2001) CD38 expression is a poor predictor for VH gene mutational status and prognosis in chronic lymphocytic leukemia. Blood 97, 1892-1894.
64. Tsirigotis, P., Pappa, V., Labropoulos, S., Papageorgiou, S., Kontsioti, F., Dervenoulas, J., Papageorgiou, E., Panani, A., Mantzios, G., Economopoulos, T., Raptis, S. (2006) Mutational and methylation analysis of the cyclin-dependent kinase 4 inhibitor (p16INK4A) gene in chronic lymphocytic leukemia. Eur. J. Haematol. 76, 230-236.
65. Ullmannova, V., Popescu, N. C. (2006) Expression profile of the tumor suppressor genes DLC1 and DLC-2 in solid tumors. Int. J. Oncol. 29, 1127-1132.
66. Vasconcelos, Y., Davi, F., Levy, V., Oppezzo, P., Magnac, C., Michel, A., Yamamoto, M., Pritsch, O., Merle-Béral, H., Maloum, K., Ajchenbaum-Cymbalista, F., Dighiero, G. (2003) Binet's staging system and VH genes are independent but complementary prognostic indicators in chronic lymphocytic leukemia. J. Clin. Oncol. 21, 3928-3932.
67. Wong, C. M., Lee, J. M., Ching, Y. P., Jin, D. Y., Ng, I. O. (2003) Genetic and epigenetic alterations of DLC1 gene in hepatocellular carcinoma. Cancer Res. 63, 7646-7651.
68. Ying, J., Li, H., Murray, P., Gao, Z., Chen, Y. W., Wang, Y., Lee, K. Y., Chan, A. T., Ambinder, R. F., Srivastava, G., Tao, Q. (2007) Tumor-specific methylation of the 8p22 tumor suppressor gene DLC1 is an epigenetic biomarker for Hodgkin, nasal NK/T-cell and other types of lymphomas. Epigenetics 2, 15-21.
69. Yuan, B. Z., Miller, M. J., Keck, C. L., Zimonjic, D. B., Thorgeirsson, S. S., Popescu, N. C. (1998) Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC1) homologous to rat RhoGAP. Cancer Res. 58, 2196-2199.
70. Yuan, B. Z., Durkin, M. E., Popescu, N. C. (2003) Promoter hypermethylation of DLC1, a candidate tumor suppressor gene, in several common human cancers. Cancer Genet. Cytogenet. 140, 113-117.
71. Yuan, B. Z., Jefferson, A. M., Baldwin, K. T., Thorgeirsson, S. S., Popescu, N. C., Reynolds, S. H. (2004) DLC1 operates as a tumor suppressor gene in human non-small cell lung carcinomas. Oncogene 23, 1405-1411.
72. Zhang, Q., Raghunath, P. N., Vonderheid, E., Odum, N., Wasik, M. A. (2000) Lack of phosphotyrosine phosphatase SHP1 expression in malignant T-cell lymphoma cells results from methylation of the SHPl promoter. Am. J. Pathol. 157, 1137-1146.